Related Experiment Video
Updated: Mar 3, 2026
09:15
In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
1.3K
Thrombolysis of prosthetic mitral valve thrombosis in an infant
Ali Hage1, Frederic Jacques1, Philippe Chetaille2
1Service of Pediatric Cardiac Surgery, Centre Mère-Enfant Soleil, CHU de Québec-Université Laval, Quebec, Canada.
Journal of Cardiac Surgery
|May 3, 2017
Insights
A 7-week-old infant with a mechanical mitral valve thrombosis was successfully treated with recombinant tissue plasminogen activator (rt-PA). This case highlights effective management strategies for pediatric mechanical prosthesis thrombosis.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Biomedical Engineering
Background:
- Mechanical heart valves are crucial for managing pediatric valvular heart disease.
- Thrombosis of mechanical prosthesis in infants presents unique clinical challenges.
- Anticoagulation and thrombolysis are key considerations in managing these complications.
Observation:
- A 7-week-old female infant presented with thrombosis of a mechanical mitral valve.
- The infant experienced symptoms related to valve dysfunction due to the clot.
- Diagnosis was confirmed through imaging studies.
Findings:
- Successful treatment of mechanical mitral valve thrombosis was achieved using recombinant tissue plasminogen activator (rt-PA).
- The infant showed significant clinical improvement following thrombolytic therapy.
- No major complications were reported during or after rt-PA administration.
Implications:
- Recombinant tissue plasminogen activator (rt-PA) represents a viable therapeutic option for infants with thrombosed mechanical heart valves.
- This case underscores the importance of prompt diagnosis and tailored treatment approaches in pediatric thrombosis.
- Further review of management strategies for infants with thrombosed mechanical prosthesis is warranted to optimize patient outcomes.
Abstract:
A 7-week-old female developed thrombosis of a mechanical mitral valve and was successfully treated with recombinant tissue plasminogen activator (rt-PA). The management of infants with thrombosed mechanical prosthesis is reviewed.
More Related Videos
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
386
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
386
01:29Venous Thrombosis III: Interprofessional Care
426
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
426
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
563
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
563
01:25Mitral Regurgitation III: Medical Management
450
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
450
01:22Mitral Valve Prolapse II: Assessment and Management
856
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
856
01:22Mitral Stenosis I: Introduction
973
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
973